Using O2 on ALS patients

You might find the following information helpful: Patients with neuromuscular diseases who are developing progressive respiratory failure due to respiratory muscle weakness will die unless mechanical ventilation is used. The rate of progression is often hard to predict. Some patients seem suddenly to experience life-threatening hypercapnic respiratory failure. They may not have been aware of gradually increasing symptoms and signs, particularly since they are often not physically active and are often not being regularly monitored with simple pulmonary function tests. Administering oxygen does not provide assistance to the weakening respiratory muscles, but gives both the patient and the doctor the false impression that appropriate treatment is being provided. While in fact hypoventilation is mistaken for an oxygen transfer problem. Indeed, administering oxygen can mask the problem. Also there is a danger of causing respiratory depression by giving oxygen (see reference to the article by Dr. Peter Gay - Mayo Clinic - below). Oxygen is NOT the treatment for hypoventilation. It will improve the SaO2, but not the hypoventilation and may increase the danger of dying of sudden respiratory failure. In hypercapnic respiratory failure due to hypoventilation, the SaO2 falls due to the rise of the CO2. The alveoli in the lungs (tiny gas exchange units) should clear most of the CO2 out with each breath. Instead, with hypoventilation, CO2 accumulates and thus there is decreased room in the alveoli for oxygen. When mechanical ventilation using room air is provided, it lowers the CO2 in the alveoli, corrects the SaO2, and rests the respiratory muscles. The ventilator should be adjusted to achieve a normal SaO2, on room air. If oxygen is being administered, one cannot use noninvasive oximetry to tell whether enough assisted ventilation is being provided; repeated arterial blood gas specimens (ABGs) would be needed. When there is respiratory failure in neuromuscular patients (ALS, post-polio, SMA, muscular dystrophy, etc.) who have no additional pulmonary disease that impairs oxygen transfer, the ventilator set-up is adjusted to: be comfortable for the patient; achieve SaO2 of 95% or higher on room air (this can be measured with a finger-sensor oximeter); assist the patient to effectively cough and clear secretions; provide improved oral communication (if vocal communication is possible). It has been common for people using noninvasive nasal ventilation (NPPV) with a bi-level positive pressure unit to use inadequate settings; frequently, they are not monitored with clinical evaluation and oximetry. The EPAP is often set too high – usually it should not be higher than 3-4 cm H2O; the IPAP is set too low – usually it needs to be 12-16 cm H2O and adjusted to achieve an oxygen saturation of 95% or higher. Some situations may require administering oxygen temporarily, such as pneumonia due to infection or aspiration. If this occurs in patients with respiratory muscle weakness and hypoventilation, then it is important to provide both assisted ventilation and supple-mental oxygen, and use ABGs to monitor them. (The late Dr. Oppenheimer, former head of pulmonary medicine at UCLA, sent me that article a few years back. He went on to tell me that when PALS are given oxygen it tricks the brain into thinking the body doesn't need to put forth the effort to breathe.)

Add new comment

Limited HTML

  • Allowed HTML tags: <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd> <p> <br> <a> <ul> <li> <strong> <b>
  • Lines and paragraphs break automatically.
  • Both <img> and <iframe> elements are lazy-loaded.

Plain text

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
CAPTCHA
This question is to prevent automated spam submissions.